Abstract
Carbon nanostructures and especially graphene oxide (GO) have attracted tremendous interest in the scientific community due to the potential utilization in numerous applications in the last decade. Herein, we describe the recent advances in the field of biotechnology and biomedicine of graphene oxide/polymer hybrids as novel nanocarriers for drug and gene delivery.
Keywords: Graphene oxide, polymers, drug and gene delivery, polyethyleneglycol.
Graphical Abstract
Current Organic Chemistry
Title:Polymer Functionalized Graphene Oxide: A Versatile Nanoplatform for Drug/Gene Delivery
Volume: 19 Issue: 18
Author(s): George V. Theodosopoulos, Panayiotis Bilalis and Georgios Sakellariou
Affiliation:
Keywords: Graphene oxide, polymers, drug and gene delivery, polyethyleneglycol.
Abstract: Carbon nanostructures and especially graphene oxide (GO) have attracted tremendous interest in the scientific community due to the potential utilization in numerous applications in the last decade. Herein, we describe the recent advances in the field of biotechnology and biomedicine of graphene oxide/polymer hybrids as novel nanocarriers for drug and gene delivery.
Export Options
About this article
Cite this article as:
V. Theodosopoulos George, Bilalis Panayiotis and Sakellariou Georgios, Polymer Functionalized Graphene Oxide: A Versatile Nanoplatform for Drug/Gene Delivery, Current Organic Chemistry 2015; 19 (18) . https://dx.doi.org/10.2174/1385272819666150526005714
DOI https://dx.doi.org/10.2174/1385272819666150526005714 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Window, a Critical Developmental Stage for Stem Cell Therapies
Current Stem Cell Research & Therapy An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Medicinal Chemistry Reviews - Online (Discontinued) Paris Saponin VII Induces Apoptosis and Cell Cycle Arrest in Erythroleukemia Cells by a Mitochondrial Membrane Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Edible Transgenic Plant Vaccines for Different Diseases
Current Pharmaceutical Biotechnology 1,3,4-Oxadiazole Derivatives as Potential Biological Agents
Mini-Reviews in Medicinal Chemistry EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
Recent Patents on Anti-Cancer Drug Discovery CASC15: A Tumor-Associated Long Non-Coding RNA
Current Pharmaceutical Design Autologus Stem Cell Transplatation as a Care Option in Elderly Patients. A Review
Anti-Cancer Agents in Medicinal Chemistry Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Mechlorethamine based Drug Structures for Intervention of Central Nervous System Tumors
Central Nervous System Agents in Medicinal Chemistry Pin1: A New Outlook in Alzheimers Disease
Current Alzheimer Research B Cell Depletion with Rituximab in Graves Disease and Associated Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Pathogenesis of Lung Cancer and Chromosome 11
Current Genomics Future Approaches for Treating Hematologic Disease
Current Pharmaceutical Biotechnology What they are, How they Work and Why they do What they do? The Story of SV40-derived Gene Therapy Vectors and What They Have to Offer
Current Gene Therapy Role of Transforming Growth Factor Beta in Corneal Function, Biology and Pathology
Current Molecular Medicine Editorial [Hot Topic: Mechanisms of Drug Sensitivity and Resistance in Cancer (Guest Editor: Lorraine ODriscoll)]
Current Cancer Drug Targets Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders
Reviews on Recent Clinical Trials The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment
Current Drug Targets